XRAYNEUTRAL

Quick Ratio

0.67x

Updated 654h ago

Sector Performance

47th percentile

XRAY

0.67x

Sector Median

0.72x

Sector Avg

3.05x

📊

Deep Analysis

A quick ratio of 0.67x means the company has $0.67 in liquid assets (like cash and receivables) for every $1.00 of current liabilities due within a year, indicating a tighter liquidity position.

This ratio sits below the sector median of 0.76x and places the company in the 42nd percentile among sector peers, meaning roughly 42% of peers have a lower quick ratio. Because year-over-year and quarter-over-quarter changes are both reported as N/A, there is no observable trend data—the metric is a single snapshot. The combination of a below-median quick ratio with no trend information suggests a current liquidity risk that is neither improving nor worsening, offering no clear opportunity from this metric alone. This neutral level supports the overall NEUTRAL verdict directly: the quick ratio is weaker than peers but not alarmingly so, and the absence of trend data removes any directional signal.

Frequently Asked Questions

What does the Quick Ratio tell investors about XRAY?

A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.

How is the Quick Ratio calculated?

Quick Ratio is calculated as: (Cash + Receivables) / Current Liabilities.

Who are XRAY's closest peers by Quick Ratio?

The closest peers by Quick Ratio include: EXR (0.16x), AWK (0.13x), DRI (0.13x), NIO (0.13x), SRE (0.11x).

The Formula

(Cash + Receivables) / Current Liabilities

Why It Matters

A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.

Advertisement

Master XRAY's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full XRAY research report

Free account — no credit card

XRAY

0.67x

Sector Median

0.72x

Sector Avg

3.05x

How XRAY's Quick Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.